. 2008 Dec 27;44(1):52–56. doi: 10.3164/jcbn.08-188

Table 1.

Bay leaves decrease serum glucose in subjects with type 2 diabetes

Doses of bay leaves and placebo (g/day)	Fasting serum glucose (mmol/L)
	Before intake of bay leaves	During intake of bay leaves			After intake of bay leaves
	Day 0	Day 10	Day 20	Day 30	Day 40
Bay Leaves 1	12.0 ± 3.6^a	9.0 ± 2.4^c	10.4 ± 3.5^b	8.9 ± 2.6^c	10.2 ± 2.7^b
Bay Leaves 2	11.3 ± 3.5^a	11.0 ± 3.2^a	10.2 ± 3.4^a	8.8 ± 2.3^b	10.5 ± 3.8^a
Bay Leaves 3	16.9 ± 4.2^a	13.3 ± 3.9^b	14.0 ± 2.7^b	13.4 ± 2.7^b	14.0 ± 3.1^b
Placebo 1	9.7 ± 4.1^a	10.3 ± 5.2^a	9.3 ± 3.8^a	9.3 ± 3.9^a	9.4 ± 3.7^a

Values are means ± SD for 10 subjects per treatment.

Means in the same row, with different superscripts, are significantly different at p<0.05. Clarification of the different means is further illustrated in bottom of Table 2.